Annals of internal medicine
-
Concomitant use of oral organic nitrates (nitrates) and phosphodiesterase type 5 (PDE5) inhibitors is contraindicated. ⋯ Ib Mogens Kristiansens Almene Fond and Helsefonden.
-
Vestergaard SV, Birn H, Darvalics B, et al. Risk of arterial thromboembolism, venous thromboembolism, and bleeding in patients with nephrotic syndrome: a population-based cohort study. Am J Med. 2022;135:615-25.e9. 34979093.